Atto Bioscience's R&D group has unique capabilities and experience developing new approaches to cell-based assays. Using proprietary cloning technology, Atto's team has the ability to introduce novel genes into cells to develop custom cell lines expressing a multitude of reporting constructs.

For additional information about accessing this capability, please contact Atto Bioscience at Atto_customservices@bd.com.